Association of Eumycetoma and Schistosomiasis
Open Access
- 23 May 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 7 (5) , e2241
Abstract
Eumycetoma is a morbid chronic granulomatous subcutaneous fungal disease. Despite high environmental exposure to this fungus in certain regions of the world, only few develop eumycetoma for yet unknown reasons. Animal studies suggest that co-infections skewing the immune system to a Th2-type response enhance eumycetoma susceptibility. Since chronic schistosomiasis results in a strong Th2-type response and since endemic areas for eumycetoma and schistosomiasis do regionally overlap, we performed a serological case-control study to identify an association between eumycetoma and schistosomiasis. Compared to endemic controls, eumycetoma patients were significantly more often sero-positive for schistosomiasis (p = 0.03; odds ratio 3.2, 95% CI 1.18–8.46), but not for toxoplasmosis, an infection inducing a Th1-type response (p = 0.6; odds ratio 1.5, 95% CI 0.58–3.83). Here, we show that schistosomiasis is correlated to susceptibility for a fungal disease for the first time. Eumycetoma is a mutilating fungal disease of mainly the foot and is found in (sub)tropical regions such as Sudan. At the moment it is not understood why some people develop eumycetoma and others not. In the regions were eumycetoma is prevalent many other infections are also found. These infections could alter the immune system which makes people more or less susceptible in obtaining another infection. One of the infections with such an effect is Schistosomiasis. In Africa, eumycetoma is found in regions were schistosomiasis is prevalent. In this study we show that eumycetoma patients more often have antibodies against Schistosoma species, than healthy controls from the same region. In contrast, eumycetoma patients did not have more often antibodies against Toxoplasma species. This might implicate that schistosomiasis predisposes eumycetoma development. If schistosomiasis indeed predisposes eumycetoma development, eradicating Schistosoma in a population could also lower the number of eumycetoma cases in that area, which in the end could lead to intervention strategies not only for schistosomiasis but also for eumycetoma.Keywords
This publication has 31 references indexed in Scilit:
- From Host Immunity to Pathogen Invasion: The Effects of Helminth Coinfection on the Dynamics of MicroparasitesIntegrative and Comparative Biology, 2011
- Plasmodium yoelii: Adverse outcome of non-lethal P. yoelii malaria during co-infection with Schistosoma mansoni in BALB/c mouse modelExperimental Parasitology, 2009
- Immunologic Responses to Vibrio cholerae in Patients Co-Infected with Intestinal Parasites in BangladeshPLOS Neglected Tropical Diseases, 2009
- Management of mycetoma: major challenge in tropical mycoses with limited international recognitionCurrent Opinion in Infectious Diseases, 2007
- Epidemiology of HCV infection in Gezira state of central SudanJournal of Medical Virology, 2007
- Subversion of innate and adaptive immune responses by Toxoplasma GondiiParasitology Research, 2006
- The Schistosoma mansoni Hepatic Egg Granuloma Provides a Favorable Microenvironment for Sustained Growth of Leishmania donovaniThe American Journal of Pathology, 2006
- Genotyping of Madurella mycetomatis by Selective Amplification of Restriction Fragments (Amplified Fragment Length Polymorphism) and Subtype Correlation with Geographical Origin and Lesion SizeJournal of Clinical Microbiology, 2005
- Established TH1 Granulomatous Responses Induced by Active Mycobacterium avium Infection Switch to TH2 Following Challenge with Schistosoma mansoniClinical Immunology, 2002
- The immunobiology of schistosomiasisNature Reviews Immunology, 2002